Everolimus-eluting bioresorbable scaffold implantation for the treatment of bifurcation lesions — Implications from early clinical experience during daily practice
The clinical performance of bioresrobable scaffolds (BRSs) in bifurcation lesion is not well investigated so far and information can currently mostly be gleaned from the results of bench testing. The present analysis evaluates the technical feasibility of BRS use in this type of lesion and its mid-term clinical outcome.
Source: Cardiovascular Revascularization Medicine - Category: Cardiology Authors: Jens Wiebe, Oliver D örr, Timm Bauer, Christoph Liebetrau, Niklas Boeder, Helge Möllmann, Christian W. Hamm, Holger M. Nef Tags: Clinical Source Type: research